AnaptysBio, Inc. (ANAB)
47.54
-0.19
(-0.40%)
USD |
NASDAQ |
Nov 04, 16:00
47.54
0.00 (0.00%)
After-Hours: 20:00
AnaptysBio Price to Book Value : 133.52 for Nov. 4, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 03, 2026 | 134.05 |
| November 02, 2026 | 131.75 |
| October 30, 2026 | 135.59 |
| October 29, 2026 | 136.61 |
| October 28, 2026 | 141.83 |
| October 27, 2026 | 139.39 |
| October 26, 2026 | 136.97 |
| October 23, 2026 | 136.86 |
| October 22, 2026 | 135.09 |
| October 21, 2026 | 134.64 |
| October 20, 2026 | 127.59 |
| October 19, 2026 | 138.29 |
| October 16, 2026 | 130.90 |
| October 15, 2026 | 136.80 |
| October 14, 2026 | 131.07 |
| October 13, 2026 | 128.04 |
| October 12, 2026 | 129.30 |
| October 09, 2026 | 129.05 |
| October 08, 2026 | 129.78 |
| October 07, 2026 | 128.21 |
| October 06, 2026 | 134.50 |
| October 05, 2026 | 138.18 |
| October 02, 2026 | 136.30 |
| October 01, 2026 | 136.58 |
| September 30, 2026 | 141.16 |
| Date | Value |
|---|---|
| September 29, 2026 | 141.46 |
| September 28, 2026 | 142.67 |
| September 25, 2026 | 143.23 |
| September 24, 2026 | 145.20 |
| September 23, 2026 | 142.59 |
| September 22, 2026 | 151.43 |
| September 21, 2026 | 154.24 |
| September 18, 2026 | 155.03 |
| September 17, 2026 | 154.64 |
| September 16, 2026 | 152.53 |
| September 15, 2026 | 153.57 |
| September 14, 2026 | 151.97 |
| September 11, 2026 | 151.29 |
| September 10, 2026 | 154.92 |
| September 09, 2026 | 156.43 |
| September 08, 2026 | 158.96 |
| September 04, 2026 | 159.52 |
| September 03, 2026 | 161.38 |
| September 02, 2026 | 156.83 |
| September 01, 2026 | 155.25 |
| August 31, 2026 | 160.17 |
| August 28, 2026 | 158.06 |
| August 27, 2026 | 160.90 |
| August 26, 2026 | 162.89 |
| August 25, 2026 | 163.93 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 22.12 |
| Anika Therapeutics, Inc. | 1.986 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.020 |
Price to Book Value Related Metrics
| PE Ratio | 7.375 |
| PS Ratio | 5.941 |
| Price to Free Cash Flow | 78.13 |
| Price | 47.54 |
| Earnings Yield | 13.56% |
| Market Cap | 1.413B |
| Operating PE Ratio | 10.54 |
| Normalized PE Ratio | 7.375 |